Search Tag: acute hypoxaemic respiratory failure
2023 22 Aug
A study aimed to improve understanding of the impact of the awake prone position on the breathing patterns of patients with low oxygen levels. The researchers carried out a crossover trial examining how awake prone position use in patients with acute hypoxaemic respiratory failure affected their physiological responses. The study involved...Read more
2023 15 Feb
Prone positioning is a medical intervention that was initially proposed over 50 years ago as a way to improve gas exchange. Multiple clinical trials have been conducted on its effectiveness, with the Proning Severe ARDS Patients landmark trial demonstrating a mortality benefit in patients with severe ARDS. As a result, expert consensus and societal...Read more
2022 20 Sep
Acute hypoxaemic respiratory failure (AHRF) is one of the main manifestations of severe COVID-19. The RECOVERY trial showed that dexamethasone 6 mg/d for ten days reduced 28-day mortality in patients with the most severe COVID-19. Another study described the benefit of high-dose dexamethasone in ARDS. However, Munch et al. found no difference between...Read more
2022 19 Apr
High flow nasal oxygen (HFNO) has many physiological benefits in patients with acute hypoxaemic respiratory failure (AHRF). It can also help reduce the need for intubation. However, optimal flow settings are unknown and are generally based on expert recommendations. Maintaining oxygenation within a given target range requires intensive patient...Read more
2022 22 Mar
Prone positioning can improve oxygenation and mortality for intubated patients with moderate to severe acute respiratory distress syndrome (ARDS). Prone positioning of non-intubated patients called awake prone positioning has been used for non-intubated patients with COVID-19 related acute hypoxaemic respiratory failure. It has been proven to improve...Read more
2021 12 Oct
Approximately 14 to 17% of COVID-19 patients admitted to the hospital require transfer to the ICU. However, there is insufficient evidence regarding the long-term survival and predictive factors for mortality in patients with acute hypoxaemic respiratory failure due to COVID-19 and undergoing invasive mechanical ventilation. A study was conducted...Read more
2021 02 Sep
Results from the awake prone positioning for COVID-19 acute hypoxaemic respiratory failure meta-trial were presented by Oriol Roca, Critical Care Specialist, Vall d'Hebron University Hospital, Barcelona, Spain, at the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine in Brussels. Awake prone positioning has been shown to...Read more
2021 01 Sep
Acute hypoxaemic respiratory failure is a leading cause of admission to ICUs and is associated with significant mortality and morbidity. Many patients affected by acute hypoxaemic respiratory failure meet the diagnostic criteria for acute respiratory distress syndrome. An important intervention that has been shown to reduce mortality in patients with...Read more
2017 28 Nov
High flow nasal cannula (HFNC) oxygenation has become an increasingly popular therapy for hypoxaemic respiratory failure. Recent studies have illuminated the effects of this device on respiratory physiology, and its impact on clinical outcomes in adults. However, because many clinical indications have not been studied, clinicians and physiologists...Read more